When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
There are more than 14 million asthmatics in the United States. This number is rising and includes approximately 4.8 million children. Their care costs about $4.6 billion dollars a year. Incidence, hospitalizations, and mortality for asthma have been increasing for many years. Asthma is like an iceberg in that the everyday symptoms do not reveal the extent of underlying disease. The patient also often downplays their degree of obstruction. Objective data via expiratory flows are necessary to establish the severity of the disease. The goal of healthcare professionals is to make the Asthma Outcomes Monitoring System (AOMS) instruments the national standard for outcome assessments in asthma and build a national database of patient outcomes from which benchmarks can be drawn for the standarized care and treatment of patients with asthma. This course discusses the types of asthma (extrinsic, intrinsic, occupational, exercise-induced, bronchial aspergillosis), pathology, causes, symptoms of acute attack, treatment, status asthmaticus, sedation, continuous nebulization, and long-term management.
- Define asthma as well as the pathology of asthma and the four main classifications of asthma.
- Identify the causes for the increasing number of asthmatics in the United States.
- Describe at least six factors that contribute to asthma exacerbations and the four components of effective asthma management.
- Give four examples of symptoms observed during the physical exam of the asthmatic.
- List six alternative diagnoses in the adult patient presenting with similar symptoms.
- Describe the result you may expect to find in the CBC and differential of an asthmatic and the typical findings of the CXR in an asthmatic.
- List and define the goals of asthma therapy and the step method of asthma treatment.
- Compare and contrast long-acting and short-acting beta2-agonist therapy in the asthmatic and the benefit which administration of anticholinergics coupled with a short acting beta2-agonist may have for the asthmatic.
- Explain the use of inhaled corticosteriods in the treatment of asthma and why mediator modifiers are helpful in the treatment of asthma.
- List and describe the seven indications for mechanical ventilation of the asthmatic.
- Describe the expected arterial blood gas values at the beginning of an asthma exacerbation and how they may change as the patient’s condition deteriorates.
- Describe the treatment for severe persistent asthma and the three pathways that have been found which generally lead to a fatal asthma attack.
- Contact hours will be awarded for up to one (1) year from the date the course is ordered, unless otherwise indicated with an expiration date.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.